Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Apixaban Versus Aspirin to Reduce Cognitive Decline After Cryptogenic Stroke and Atrial Cardiopathy: ARCADIA‐Cognition Study

Journal of the American Heart Association(2025)10.1161/jaha.125.042147Source: DataRank Database

Apixaban Versus Aspirin to Reduce Cognitive Decline After Cryptogenic Stroke and Atrial Cardiopathy: ARCADIA‐Cognition Study is a research paper published in Journal of the American Heart Association (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access0 citations

Download PDF

Cite:

Linked data & code

nct doi

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT03192215

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.00)OA: goldTopics (38)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

George Howard ORCID,Michael Brewer ORCID,Christy Cassarly ORCID,Qi Pauls ORCID,Stephanie Kemp ORCID

Live enrichment

PubMed:40847528 PMC:PMC12554400 OpenAlex:https://openalex.org/W4413443774

NINDS NIH HHS

Grant: U01 NS110728

NINDS NIH HHS

Grant: U24 NS107220

FWCI

0.00

Citation Percentile

0.3%

goldLicense: cc-by-nc-nd

journalhttps://www.ahajournals.org/doi/pdf/10.1161/JAHA.125.042147

publisherhttps://www.ahajournals.org/doi/pdf/10.1161/JAHA.125.042147

publisherhttps://www.ahajournals.org/doi/full/10.1161/JAHA.125.042147

journalhttps://doi.org/10.1161/jaha.125.042147

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40847528

Fields of Study

Atrial Fibrillation Management and OutcomesCardiovascular and Diving-Related ComplicationsCardiac electrophysiology and arrhythmias

MeSH Terms

Ischemic StrokeAgedAspirinCognitionFemaleFibrinolytic AgentsHumansMaleMiddle AgedPlatelet Aggregation InhibitorsPyrazolesPyridonesTime FactorsTreatment OutcomeSecondary PreventionCognitive DysfunctionFactor Xa Inhibitors

Keywords

MedicineAspirinArcadiaCognitive declineApixabanStroke (engine)CognitionCardiologyInternal medicineAtrial fibrillationDementiaIntensive care medicineWarfarinRivaroxabanPsychiatryDiseaseAtrial CardiopathyCovert Infarction

Apixaban Versus Aspirin to Reduce Cognitive Decline After Cryptogenic Stroke and Atrial Cardiopathy: ARCADIA‐Cognition Study

FAIR Checklist

Authors (14)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)